The pharmaceutical industry is starting to adjust its approach and take advantage of new market opportunities from climate change. Medical device manufacturers are already meeting increasing demand for telemedicine solutions in remote areas in Africa. Belatedly, pharmaceutical companies are following suit. Bayer, the German pharma giant, is collaborating with mobile health clinics and local healthcare providers in Africa to expand access to quality healthcare services and to bring essential healthcare services directly to remote communities.
Pharmaceutical firms joined world leaders and health groups to announce $1.2 billion in funding for the African Vaccine Manufacturing Accelerator to produce vaccines in Africa which imports 99 percent of its vaccines at exorbitant costs. Following rising cholera cases from climate change, armed conflict and displacements, the Biovac Institute partnered with the International Vaccine Institute (IVI) in 2022 to strengthen cholera vaccine production capacity in Africa, a collaboration focused on licensing and technology transfer.